The importance of a global COVID-19 vaccination strategy and how WHO involvement benefits the U.S. overall are topics that institute director Richard Marlink discusses in this Q&A.
Race to Vaccinate
Appearing on CNBC’s Power Lunch, core faculty member and Rutgers vice chancellor Reynold Panettieri discusses the Johnson & Johnson COVID-19 vaccine, infection rates and hospitalizations, and effective public health measures.
When it comes to vaccine efficacy, here’s why 94% isn’t much different than 72%
In an interview about the efficacy of COVID-19 vaccines, institute director Richard Marlink responds to public opinion about the differences among vaccines that are authorized or in the pipeline for use in the United States.
Social and Structural Factors, Not Biology, are Strong Influencers of Racial Disparities in COVID-19 Mortality
Racial disparities in COVID-19 mortality in the U.S. are associated with social factors like income, education, and internet access, according to a Rutgers study published in the Journal of Racial and Ethnic Health Disparities.
Rutgers professor explains consequences of coronavirus vaccine hoarding
The global health consequences and moral implications of wealthy countries hoarding vaccines could be quite serious, said institute director Richard Marlink in a story published by The Daily Targum.
Will you need an annual vaccination for COVID-19?
In a television interview broadcast by NJ Spotlight News, institute director Richard Marlink discusses the COVID-19 vaccine. Topics include how long immunity might last and roadblocks in rolling out a vaccination program.
Getting Back to Work and School Safely During COVID-19: ITI Students Help Launch HLTH I.D
School of Communication and Information students developed an app intended to detect COVID-19. Institute director Richard Marlink was the student team’s industry mentor in the Rutgers I-Corps program.
Project Map Spotlight: Advanced Stage Breast Cancer in Botswana
Breast cancer is a leading cause of cancer-related deaths in Botswana, and there is a dire need to improve timely access to care. Through research and training, the Botswana-Rutgers Partnership for Health is working to identify and address crucial deficiencies in information and support.
No Longer a Death Sentence: Transforming Cancer Care and Prevention in Africa
A Rutgers Global Health Institute initiative combines advancements in telemedicine with lessons learned from earlier battles against HIV to increase cancer survival rates in an area that needs it the most.
Improving Cancer Care in Botswana: An International Partnership
In Botswana, there is a severe shortage of nurses who have advanced training in oncology and palliative care. To address the challenges this poses to the African nation’s ability to provide comprehensive cancer care, nurse leaders in Botswana and at Rutgers are collaborating to expand specialty education and training.